The 2 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 9.00. The median estimate represents a +107.51% increase from the last price of 5.06.
The current consensus among 2 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.66
Reporting Date Feb 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.